Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non-Hodgkin lymphomas: A phase IB/II study.

Tycel Jovelle PhillipsMark BrunvandAndy I ChenJames EssellAnnalisa ChiappellaCatherine DiefenbachJi ChengDavid RamiesJamie HirataFranck MorschhauserIan W Flinn

Published in: American journal of hematology (2021)

Keyphrases

hodgkin lymphoma
acute lymphoblastic leukemia
acute myeloid leukemia
diffuse large b cell lymphoma
multiple myeloma